Measures reflective of center adherence with CFRD care guidelines
| Recommended test, results are n and per cent of reviewed patients | First chart review n=69 | Second chart review n=87 | p Value |
|---|---|---|---|
| Insulin usage | 50 (72) | 64 (73) | 0.98* |
| Patients with more than 6 clinic visits annually† | 28 (40) | 15 (17) | 0.002* |
| Retinal eye examination | 14 (20) | 38 (44) | 0.004* |
| Foot examinations | 14 (20) | 38 (44) | 0.004* |
| Albuminuria testing | 6 (9) | 52 (60) | <0.001* |
| Any HbA1c measurements | 52 (75) | 69 (79) | 0.69* |
| 3 or more HbA1c measurements in 1 year, n (%) | 1 (1) | 14 (16) | 0.005* |
*Pearson's χ2.
†The CF Foundation recommends four visits annually for routine follow-up and maintenance of health. Additional visits are generally for acute illnesses, and a reduction in these visits is a generally desirable outcome.
CF, cystic fibrosis; CFRD, CF-related diabetes; HbA1c, glycated hemoglobin.